查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390425

脱髮治疗市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Alopecia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球脱髮治疗市场规模达到31亿美元。展望未来， IMARC Group预计到2028年市场规模将达到41亿美元，2022-2028年复合年增长率（CAGR）为4.77%。脱髮率的不断上升、人们对脱髮状况和治疗方法的认识不断增强、医疗技术和治疗方法的进步以及政府支持性政策的实施是推动市场发展的一些主要因素。

脱髮治疗是指用于控制和对抗脱髮的各种方法，脱髮是一种以严重脱髮为特征的疾病。脱髮的类型包括雄性秃、斑秃和疤痕性脱髮。脱髮治疗包括局部治疗、口服药物、植髮手术、光疗法和富血小板血浆疗法。它有助于减缓脱髮进展、促进头髮再生、保持头髮健康、改善外观并增强自信。

脱髮（包括雄性秃和斑秃）盛行率的上升是推动有效治疗需求的关键因素之一。此外，提供具有成本效益的毛髮移植手术的国家的医疗旅游业不断增长，也推动了市场的成长。此外，快速的城市化，加上可支配收入的增加，使个人能够负担得起高品质的治疗计划，也促进了市场的成长。除此之外，製药公司透过社群媒体和有影响力的行销来提高消费者对新产品和治疗方法的认识，采取积极的营销和促销策略，有利于市场成长。此外，远距医疗的出现使获得医疗咨询和处方变得更加容易，这正在加强市场的成长。其他因素，包括对个人化医疗不断增长的需求、广泛的研发 (R&D) 活动以及时尚和娱乐产业影响力的不断上升，预计将推动市场成长。

脱髮治疗市场趋势/驱动因素：

脱髮症的盛行率日益增加

脱髮包括一系列脱发病症，在全球范围内越来越普遍。其诱因包括遗传倾向、荷尔蒙失衡、压力和生活方式因素，如营养不良、吸烟、接触化学物质和久坐的生活方式。这些触发因素正在增加，尤其是在老化人口和在高压力环境中工作的个人。与此一致的是，由于现代生活的快节奏和压力，压力引起的脱髮明显增加。同时，随着人口的增长和遗传特征的传递，与遗传密切相关的雄性秃等疾病变得越来越普遍。此外，多囊性卵巢症候群（PCOS）和甲状腺疾病等慢性疾病的盛行率不断上升，这些疾病可能导致脱髮，也导致脱髮病例数量不断增加。

人们对脱髮状况和治疗的认识不断增强

由于网路上提供的资讯激增以及透过协调一致的宣传活动，消费者对脱髮状况的认识不断增强，这是推动市场成长的关键因素之一。各种健康平台、社交媒体和有影响力的社区正在积极讨论脱髮及其影响和可能的补救措施，使这个话题不再那么禁忌，更容易被大众所理解。这种意识的提高引发了态度的转变，导致人们更倾向于寻求专业协助和建议。人们对脱髮的污名化，加上人们认识到脱髮是一种可以治疗的疾病，大大增加了对治疗的需求。此外，知情的消费者更有可能长期坚持治疗方案，这是另一个成长诱导因素。

医疗技术和治疗方法的进步

毛髮学领域，即头髮和头皮的研究，近年来见证了重大的技术进步。增强型诊断工具的引入可以更准确地识别脱髮类型，从而提供更有针对性的治疗，正在推动市场成长。此外，采用新的治疗方案，包括低强度光疗法和富血小板血浆疗法，拓宽了治疗范围并改善了患者的治疗结果。此外，最近开发的局部应用和口服创新药物提高了脱髮治疗的功效，也促进了市场的成长。这些进步丰富了消费者可用的治疗选择，并增强了他们对这些治疗有效性的信心。因此，越来越多的人投资脱髮治疗和治疗，从而推动市场成长。

脱髮治疗行业细分：

IMARC Group提供了全球脱髮治疗市场报告各细分市场主要趋势的分析，以及 2023-2028 年全球、区域和国家层面的预测。我们的报告根据药物类型、适应症、性别、给药途径和配销通路对市场进行了分类。

按药物类型细分：

米诺地尔

非那雄胺

其他的

米诺地尔占据市场主导地位

该报告根据类型提供了详细的市场细分和分析。这包括米诺地尔、非那雄胺等。报告称，米诺地尔代表了最大的细分市场。

米诺地尔在市场上占据主导地位，因为其有效性和安全性已在众多临床研究中得到充分证明，使其成为医生和患者值得信赖的选择。它也是少数在全球各个监管机构批准用于治疗男性和女性型秃髮的疗法之一。此外，它通常是局部应用的，并且可以轻鬆融入日常生活中。与手术治疗相比，该应用的非侵入性性质吸引了许多患者。此外，米诺地尔有不同的形式，如泡沫、乳液和洗髮水，提供了一系列适合个人喜好的选择。除此之外，它无需处方即可在柜檯（OTC）获得，这使得患者更容易获得。

按指示细分：

雄性秃

斑秃

全秃

其他的

雄性秃主导市场

该报告根据该指标提供了详细的市场细分和分析。这包括雄性秃、斑秃、全秃等。根据该报告，雄性秃是最大的细分市场。

由于其高盛行率，雄性秃在脱髮治疗市场上占据主导地位。这是最常见的脱髮类型，影响很大一部分人口，尤其是随着年龄的增长。此外，社会和个人认为脱髮是一种消极或不良状况，这也推动了治疗需求。头髮通常与吸引力、年轻和健康联繫在一起，因此脱髮会导致自尊和自信下降，促使人们寻求治疗。此外，雄性秃具有很强的遗传因素，如果不治疗，往往会进展，使其成为长期、持续治疗方法的目标。这提供了对治疗产品和疗法的稳定需求。除此之外，雄性秃治疗方案的显着进步，包括药物和手术干预，是另一个生长诱导因素。

按性别划分：

男性

女性

女性主导市场

该报告根据性别对市场进行了详细的细分和分析。这包括男性和女性。报告称，女性代表了最大的细分市场。

由于社会压力和美容标准，女性患者在市场上占据主导地位，这使得她们更有可能寻求治疗。此外，头髮通常被视为女性身份和外表的重要组成部分，脱髮会对心理产生深远的影响，导致自尊和自信下降。此外，与男性脱髮相比，女性脱髮有更多的治疗选择。其中包括荷尔蒙疗法、局部治疗和植髮，让女性有更多机会找到适合她们的治疗方法。此外，导致女性脱髮的因素比男性更广泛，包括荷尔蒙变化、压力、饮食、某些医疗状况和药物，导致更多女性脱髮。

依给药途径分类：

口服

专题

可注射

话题主导市场

该报告根据给药途径对市场进行了详细的细分和分析。这包括口服、局部和注射。根据该报告，局部用药代表了最大的细分市场。

局部给药途径在市场上占据主导地位，因为它被用作防止脱髮的第一道防线。此外，局部治疗是非侵入性的，通常患者耐受性良好。它们可以很容易地应用于受影响的区域，从而实现有针对性的治疗。这种局部应用降低了全身副作用的风险，使其成为许多患者的更安全的选择。此外，它们比头髮移植和雷射治疗等其他治疗方案更实惠、更容易获得。此外，它们很容易透过非处方药 (OTC) 或处方获得，这使患者更加方便。除此之外，局部治疗的使用非常适合日常生活，因为患者可以在家中使用这些药物，而无需定期去医生办公室或诊所就诊。这方面的便利性大大提高了患者的依从性，有助于提高治疗效果。

按配销通路划分：

医院

零售药局

网路药局

医院主导市场

该报告根据配销通路对市场进行了详细的细分和分析。这包括医院、零售药局和网路药局。报告称，医院是最大的细分市场。

医院由于提供广泛的治疗选择（包括手术和非手术脱髮解决方案）而在脱髮治疗市场占据主导地位。此外，他们配备了最新的医疗设备和技术，使他们能够提供先进的治疗方法，如毛髮移植手术、雷射治疗和类固醇注射。此外，医院还聘请经验丰富的工作人员和专业医生，包括皮肤科医生和毛髮科医生，他们擅长诊断和治疗不同类型的脱髮。这些专业人员能够根据患者的个人情况指导患者选择有效的治疗方案。此外，他们还拥有内部药房，使患者能够更方便地获得处方药，从而提高对治疗方案的依从性，从而获得更好的结果。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美在市场上表现出明显的主导地位，占据最大的脱髮治疗市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是最大的细分市场。

由于斑秃和雄性秃的高发病率，北美在市场上占据主导地位，这增加了对有效治疗的需求。此外，由于卫生当局和公司进行广泛的教育活动，人们对这种疾病和可用治疗方法的认识不断提高，这也促进了市场的成长。此外，该地区强大的医疗基础设施和不断增长的支出能力使患者更容易获得高品质的治疗。此外，这些治疗方法的保险覆盖范围广泛，对于让更多人能够负担得起这些治疗方法发挥关键作用。除此之外，该地区积极从事新疗法研究和开发的主要製药和生物技术公司的存在正在推动市场成长。

竞争格局：

市场主要参与者正在积极投资于研发 (R&D) 计划，以发现创新、有效的脱髮治疗方法。这包括开发新药、新的应用技术以及从不同角度解决脱髮问题的治疗方法，例如针对荷尔蒙水平、减少发炎或刺激毛囊。此外，领先公司还与生物技术公司、研究机构和大学建立策略伙伴关係和合作，以加快发现步伐并彙集资源和专业知识。此外，顶尖公司也致力于透过传统和数位行销管道提高消费者对各种脱髮治疗的可用性和有效性的认识。此外，主要市场参与者正在进行严格的临床试验，以确保其产品符合严格的医疗标准和监管要求。

该报告对全球脱髮治疗市场的竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

Aclaris 治疗公司

赛尔米有限公司

西普拉有限公司

雷迪博士实验室有限公司

葛兰素史克公司

HCell公司

强生公司

默克公司

辉瑞公司

大正製药控股股份有限公司

梯瓦製药工业股份有限公司

最近的发展：

2022年8月，Aclaris Therapeutics Inc.宣布与礼来公司签署非专属专利授权协议，使用礼来公司的JAK抑制剂治疗斑秃（AA）。

2021年9月，Dr. Reddy's Laboratories Ltd.推出了治疗女性型秃头（FPHL）的新药

2023 年 6 月，FDA 批准了辉瑞公司名为 Litfulo 的新型口服疗法，用于治疗青少年脱髮。

本报告回答的关键问题

  • 2022年全球脱髮治疗市场规模是多少
  • 2023-2028年全球脱髮治疗市场的预期成长率是多少
  • 推动全球脱髮治疗市场的关键因素是什么
  • COVID-19 对全球脱髮治疗市场有何影响
  • 根据药物类型，全球脱髮治疗市场的细分情况如何
  • 根据适应症，全球脱髮治疗市场的细分是什么
  • 全球脱髮治疗市场按性别分類的情况如何
  • 根据给药途径，全球脱髮治疗市场的细分情况如何
  • 基于配销通路的全球脱髮治疗市场的细分是什么
  • 10. 全球脱髮治疗市场的重点区域有哪些？
  • 11. 全球脱髮治疗市场的主要参与者/公司有哪些？

本报告回答的关键问题

  • 2022年全球脱髮治疗市场规模有多大？
  • 2023-2028年全球脱髮治疗市场的预期成长率是多少？
  • 推动全球脱髮治疗市场的关键因素是什么？
  • COVID-19 对全球脱髮治疗市场有何影响？
  • 根据药物类型，全球脱髮治疗市场的细分情况如何？
  • 根据适应症，全球脱髮治疗市场的细分情况如何？
  • 全球脱髮治疗市场按性别分類的情况如何？
  • 根据给药途径，全球脱髮治疗市场的细分情况如何？
  • 基于配销通路的全球脱髮治疗市场的细分是什么？
  • 全球脱髮治疗市场的关键地区有哪些？
  • 全球脱髮治疗市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球脱髮治疗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按药物类型分類的市场细分

  • 米诺地尔
    • 市场走向
    • 市场预测
  • 非那雄胺
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：按迹象分類的市场

  • 雄性秃
    • 市场走向
    • 市场预测
  • 斑秃
    • 市场走向
    • 市场预测
  • 全秃
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按性别分類的市场区隔

  • 男性
    • 市场走向
    • 市场预测
  • 女性
    • 市场走向
    • 市场预测

第 9 章：按管理途径分類的市场

  • 口服
    • 市场走向
    • 市场预测
  • 专题
    • 市场走向
    • 市场预测
  • 可注射
    • 市场走向
    • 市场预测

第 10 章：按配销通路分類的市场细分

  • 医院
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 网路药局
    • 市场走向
    • 市场预测

第 11 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Aclaris Therapeutics Inc.
    • Cellmid Limited
    • Cipla Limited
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • HCell Inc.
    • Johnson & Johnson
    • Merck & Co. Inc.
    • Pfizer Inc.
    • Taisho Pharmaceutical Holdings Co. Ltd
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112023A4147

Abstract

The global alopecia treatment market size reached US$ 3.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2028, exhibiting a growth rate (CAGR) of 4.77% during 2022-2028. The increasing prevalence of alopecia, growing awareness about hair loss conditions and treatments, advancements in medical technologies and therapeutics, and the implementation of supportive government policies are some of the major factors propelling the market.

Alopecia treatment refers to various methodologies used to manage and combat Alopecia, a condition characterized by significant hair loss. The types of alopecia include androgenetic alopecia, alopecia areata, and cicatricial alopecia. Alopecia treatment consists of topical treatments, oral medications, hair transplant surgery, light therapy, and platelet-rich plasma therapy. It aids in slowing down hair loss progression, promoting hair regrowth, maintaining healthy hair, improving physical appearance, and enhancing self-confidence.

The rising prevalence of alopecia, including androgenetic alopecia and alopecia areata, is one of the key factors driving the demand for effective treatments. In addition, the rising medical tourism to countries offering cost-effective hair transplant procedures is fueling the market growth. Furthermore, rapid urbanization, coupled with the increasing disposable income, which allows individuals to afford high-quality treatment plans is contributing to the market growth. Apart from this, the aggressive marketing and promotional strategies by pharmaceutical companies through social media and influencer marketing to enhance consumer awareness about new products and treatments is favoring the market growth. Moreover, the emergence of telemedicine, which enables easier access to medical consultations and prescriptions is strengthening the market growth. Other factors, including the growing demand for personalized medicine, extensive research and development (R&D) activities, and the rising influence of fashion and entertainment industries, are anticipated to drive the market growth.

Alopecia Treatment Market Trends/Drivers:

The increasing prevalence of alopecia

Alopecia, encompassing a spectrum of hair loss conditions, is increasingly prevalent across the globe. Its triggers, include genetic predispositions, hormonal imbalances, stress, and lifestyle factors, such as poor nutrition, smoking, exposure to chemicals, and sedentary lifestyle. These triggers are rising especially in ageing populations and individuals working in highly stressful environments. In line with this, stress-induced Alopecia has witnessed a noticeable upswing due to the rapid pace and pressures of modern living. Along with this, conditions such as androgenetic alopecia, which has a strong genetic link, are becoming more common as populations grow and genetic traits are passed on. Moreover, the increasing prevalence of chronic diseases, such as polycystic ovary syndrome (PCOS) and thyroid disorders, which can lead to hair loss, is also contributing to the rising number of Alopecia cases.

The growing awareness about hair loss conditions and Treatments

The growing consumer awareness regarding hair loss conditions owing to an explosion of information available online and through concerted awareness campaigns is one of key factors propelling the market growth. Various health platforms, social media, and influencer communities are actively discussing hair loss, its implications, and possible remedies, making the topic less taboo and more understood among the masses. This heightened awareness has triggered a shift in attitudes, leading to a higher propensity to seek professional help and advice. The destigmatization of hair loss, coupled with the understanding that Alopecia is a treatable condition, has substantially increased the demand for treatments. Moreover, informed consumers are more likely to persist with the treatment regime for an extended period, which is acting as another growth-inducing factor.

Advancements in medical technologies and therapeutics

The field of trichology, the study of hair and scalp, has witnessed significant technological advancements in recent years. The introduction of enhanced diagnostic tools, which allows more precise identification of the Alopecia type and, therefore, more targeted treatments is boosting the market growth. Additionally, the adoption of novel treatment options, including low-level light therapy and platelet-rich plasma therapy, has broadened the treatment spectrum and improved patient outcomes. Furthermore, the recent development of innovative drugs for topical application and oral ingestion, which has improved the efficacy of Alopecia treatment is contributing to the market growth. These advancements have enriched the array of treatment options available to consumers and boosted their confidence in the effectiveness of these treatments. As a result, more individuals are investing in Alopecia treatment and therapies, thus propelling the market growth.

Alopecia Treatment Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global alopecia treatment market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on drug type, indication, gender, route of administration and distribution channel.

Breakup by Drug Type:

Minoxidil

Finasteride

Others

Minoxidil dominates the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes minoxidil, finasteride, and others. According to the report, minoxidil represented the largest market segment.

Minoxidil is dominating the market because its effectiveness and safety have been well-documented in numerous clinical studies, making it a trusted option for both physicians and patients. It is also one of the few treatments approved by various regulatory bodies across the globe for treating male and female pattern baldness. Furthermore, it is typically applied topically and can be incorporated into daily routines without much hassle. The non-invasive nature of the application, compared to surgical treatments, appeals to many patients. Moreover, Minoxidil is available in different forms, such as foams, lotions, and shampoos, offering a range of options to fit individual preferences. Apart from this, it can be obtained over the counter (OTC) without a prescription, which makes it more accessible to patients.

Breakup by Indication:

Androgenic Alopecia

Alopecia Areata

Alopecia Totalis

Others

Androgenic alopecia dominates the market

The report has provided a detailed breakup and analysis of the market based on the indication. This includes androgenic alopecia, alopecia areata, alopecia totalis, and others. According to the report, androgenic alopecia represented the largest market segment.

Androgenic alopecia is dominating the alopecia treatment market due to its high prevalence. It is the most common type of hair loss, affecting a significant percentage of the population, especially with increasing age. In addition, societal and personal perceptions of hair loss as a negative or undesirable condition drive demand for treatment. Hair is often associated with attractiveness, youth, and health, so hair loss can lead to lower self-esteem and confidence, prompting individuals to seek treatment. Moreover, androgenic alopecia has a strong genetic component and tends to be progressive if not treated, making it a target for long-term, sustained treatment approaches. This offers a steady demand for treatment products and therapies. Apart from this, the significant advancements in the treatment options for androgenic alopecia, including both pharmaceutical and surgical interventions, are acting as another growth-inducing factor.

Breakup by Gender:

Male

Female

Female dominates the market

The report has provided a detailed breakup and analysis of the market based on gender. This includes male and female. According to the report, female represented the largest market segment.

Female patients are dominating the market due to societal pressures and beauty standards, making them more likely to seek treatment. In addition, hair is often seen as a significant part of a woman's identity and appearance, and hair loss can have a profound psychological impact, leading to lower self-esteem and confidence. Furthermore, there are more treatment options available for female-pattern hair loss compared to male-pattern baldness. These include hormone therapy, topical treatments, and hair transplantation, giving women more opportunities to find a treatment that works for them. Additionally, hair loss in women can be caused by a wider range of factors than in men, including hormonal changes, stress, diet, certain medical conditions, and medications, leading to a larger proportion of women experiencing hair loss.

Breakup by Route of Administration:

Oral

Topical

Injectable

Topical dominates the market

The report has provided a detailed breakup and analysis of the market based on the route of administration. This includes oral, topical, and injectable. According to the report, topical represented the largest market segment.

The topical route of administration is dominating the market as it is used as the first line of defense against hair loss. In addition, topical treatments are non-invasive and generally well-tolerated by patients. They can be easily applied to the affected area, allowing for targeted treatment. This localized application reduces the risk of systemic side effects, making it a safer option for many patients. Moreover, they are more affordable and accessible than other treatment options, such as hair transplants and laser treatments. Additionally, they are readily obtained over the counter (OTC) or through prescriptions, making them more convenient for patients. Apart from this, the use of topical treatments fits well into daily routines as patients can apply these medications at home, eliminating the need for regular visits to the doctor's office or clinic. This aspect of convenience greatly increases patient compliance, contributing to the efficacy of the treatment.

Breakup by Distribution Channel:

Hospitals

Retail Pharmacies

Online Pharmacies

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on distribution channel. This includes hospitals, retail pharmacies, and online pharmacies. According to the report, hospitals represented the largest market segment.

Hospitals are dominating the alopecia treatment market due to the wide range of treatment options they provide, including both surgical and non-surgical solutions for hair loss. In addition, they are equipped with the latest medical equipment and technologies, allowing them to provide advanced treatments such as hair transplantation surgeries, laser therapies, and steroid injections. Furthermore, hospitals employ experienced staff and specialized doctors, including dermatologists and trichologists, who are skilled in diagnosing and treating different types of alopecia. These professionals are able to guide patients toward effective treatment options based on their individual conditions. Additionally, they have in-house pharmacies, making it more convenient for patients to access prescribed medications, which improves adherence to treatment regimens, leading to better outcomes.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market, accounting for the largest alopecia treatment market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represented the largest market segment.

North America is dominating the market due to a high prevalence of alopecia areata and androgenetic alopecia, which has increased the need for effective treatments. Additionally, the escalating awareness about the condition and available treatments owing to extensive educational campaigns by health authorities and companies is contributing to the market growth. Furthermore, the robust healthcare infrastructure and rising expenditure capacities in the region make it easier for patients to access high-quality treatment. In addition, the widespread availability of insurance coverage for these treatments plays a critical role in making them more affordable for a larger segment of the population. Apart from this, the presence of major pharmaceutical and biotech companies in the region that are actively engaged in the research and development of new treatments is boosting the market growth.

Competitive Landscape:

The key players in the market are actively investing in research and development (R&D) initiatives to discover innovative, effective treatments for alopecia. This includes the development of new drugs, novel application techniques, and treatments that tackle alopecia from different angles, such as targeting hormone levels, reducing inflammation, or stimulating hair follicles. Furthermore, leading companies are engaged in strategic partnerships and collaborations with biotech companies, research institutions, and universities to accelerate the pace of discovery and to pool resources and expertise. Additionally, the top companies are focusing on raising consumer awareness about the availability and effectiveness of various alopecia treatments through traditional and digital marketing channels. Moreover, key market players are conducting rigorous clinical trials to ensure their products meet stringent medical standards and regulatory requirements.

The report has provided a comprehensive analysis of the competitive landscape in the global alopecia treatment market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Aclaris Therapeutics Inc.

Cellmid Limited

Cipla Limited

Dr. Reddy's Laboratories Ltd.

GlaxoSmithKline plc

HCell Inc.

Johnson & Johnson

Merck & Co. Inc.

Pfizer Inc.

Taisho Pharmaceutical Holdings Co. Ltd

Teva Pharmaceutical Industries Ltd.

Recent Developments:

In Aug 2022, Aclaris Therapeutics Inc. announced a non-exclusive patent license agreement with Eli Lilly and Company to use Lilly's JAK inhibitor to treat alopecia areata (AA).

In September 2021, Dr. Reddy's Laboratories Ltd. launched a new drug to treat female pattern hair loss (FPHL)

In June 2023, FDA approved Pfizer's new oral treatment called Litfulo for treating alopecia in teens.

Key Questions Answered in This Report

  • 1. What was the size of the global alopecia treatment market in 2022?
  • 2. What is the expected growth rate of the global alopecia treatment market during 2023-2028?
  • 3. What are the key factors driving the global alopecia treatment market?
  • 4. What has been the impact of COVID-19 on the global alopecia treatment market?
  • 5. What is the breakup of the global alopecia treatment market based on the drug type?
  • 6. What is the breakup of the global alopecia treatment market based on the indication?
  • 7. What is the breakup of the global alopecia treatment market based on gender?
  • 8. What is the breakup of the global alopecia treatment market based on the route of administration?
  • 9. What is the breakup of the global alopecia treatment market based on the distribution channel?
  • 10. What are the key regions in the global alopecia treatment market?
  • 11. Who are the key players/companies in the global alopecia treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Alopecia Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Minoxidil
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Finasteride
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Androgenic Alopecia
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Alopecia Areata
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Alopecia Totalis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Gender

  • 8.1 Male
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Female
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

  • 9.1 Oral
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Topical
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Injectable
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Distribution Channel

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Retail Pharmacies
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Online Pharmacies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Aclaris Therapeutics Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
    • 16.3.2 Cellmid Limited
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 Cipla Limited
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Dr. Reddy's Laboratories Ltd.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 GlaxoSmithKline plc
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 HCell Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Johnson & Johnson
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Merck & Co. Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Pfizer Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Taisho Pharmaceutical Holdings Co. Ltd
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Teva Pharmaceutical Industries Ltd.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Alopecia Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Alopecia Treatment Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Alopecia Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Alopecia Treatment Market: Breakup by Drug Type (in %), 2022
  • Figure 5: Global: Alopecia Treatment Market: Breakup by Indication (in %), 2022
  • Figure 6: Global: Alopecia Treatment Market: Breakup by Gender (in %), 2022
  • Figure 7: Global: Alopecia Treatment Market: Breakup by Route of Administration (in %), 2022
  • Figure 8: Global: Alopecia Treatment Market: Breakup by Distribution Channel (in %), 2022
  • Figure 9: Global: Alopecia Treatment Market: Breakup by Region (in %), 2022
  • Figure 10: Global: Alopecia Treatment (Minoxidil) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Alopecia Treatment (Minoxidil) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Alopecia Treatment (Finasteride) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Alopecia Treatment (Finasteride) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Alopecia Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Alopecia Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Alopecia Treatment (Androgenic Alopecia) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Alopecia Treatment (Androgenic Alopecia) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Alopecia Treatment (Alopecia Areata) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Alopecia Treatment (Alopecia Areata) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Alopecia Treatment (Alopecia Totalis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Alopecia Treatment (Alopecia Totalis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Alopecia Treatment (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Alopecia Treatment (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Alopecia Treatment (Male) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Alopecia Treatment (Male) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Alopecia Treatment (Female) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Alopecia Treatment (Female) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Alopecia Treatment (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Alopecia Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Alopecia Treatment (Topical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Alopecia Treatment (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Alopecia Treatment (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Alopecia Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Alopecia Treatment (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Alopecia Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Alopecia Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Alopecia Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Alopecia Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Alopecia Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: North America: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: North America: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: United States: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: United States: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Canada: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Canada: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Asia-Pacific: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Asia-Pacific: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: China: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: China: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Japan: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Japan: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: India: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: India: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: South Korea: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: South Korea: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Australia: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Australia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Indonesia: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Indonesia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Europe: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Europe: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Germany: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Germany: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: France: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: France: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: United Kingdom: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: United Kingdom: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Italy: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Italy: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Spain: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Spain: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Russia: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Russia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Latin America: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Latin America: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Brazil: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Brazil: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Mexico: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Mexico: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Middle East and Africa: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Middle East and Africa: Alopecia Treatment Market: Breakup by Country (in %), 2022
  • Figure 88: Middle East and Africa: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Global: Alopecia Treatment Industry: SWOT Analysis
  • Figure 90: Global: Alopecia Treatment Industry: Value Chain Analysis
  • Figure 91: Global: Alopecia Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Alopecia Treatment Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Alopecia Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
  • Table 3: Global: Alopecia Treatment Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Alopecia Treatment Market Forecast: Breakup by Gender (in Million US$), 2023-2028
  • Table 5: Global: Alopecia Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 6: Global: Alopecia Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 7: Global: Alopecia Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Alopecia Treatment Market: Competitive Structure
  • Table 9: Global: Alopecia Treatment Market: Key Players